The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension | Zendy

Zheyong Huang | Zendy; Jiatian Cao | Zendy; Yumeng Yao | Zendy; Xuejuan Jin | Zendy; Zhe Luo | Zendy; Yuan Xue | Zendy; Chouwen Zhu | Zendy; Yanan Song | Zendy; Ying Wang | Zendy; Yunzeng Zou | Zendy; Juying Qian | Zendy; Kaihuan Yu | Zendy; Hui Gong | Zendy; Junbo Ge | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

Author(s) -

Zheyong Huang,

Jiatian Cao,

Yumeng Yao,

Xuejuan Jin,

Zhe Luo,

Yuan Xue,

Chouwen Zhu,

Yanan Song,

Ying Wang,

Yunzeng Zou,

Juying Qian,

Kaihuan Yu,

Hui Gong,

Junbo Ge

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.03.229

Subject(s) - medicine , angiotensin receptor blockers , covid-19 , blood pressure , troponin i , angiotensin converting enzyme , disease , troponin , renin–angiotensin system , myocardial infarction , infectious disease (medical specialty)

We observed there was no obvious difference in clinical characteristics between RAS blockers and non-RAS blockers groups. These data suggest ACEIs/ARBs may have few effects on increasing the clinical severe conditions of COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research